Back to Search
Start Over
Pulmonary Metastasectomy for Germ Cell Tumors.
- Source :
-
Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia [Ann Thorac Cardiovasc Surg] 2019 Dec 20; Vol. 25 (6), pp. 289-295. Date of Electronic Publication: 2019 Nov 13. - Publication Year :
- 2019
-
Abstract
- Germ cell tumors (GCTs) are the most common malignancy among young men in the United States. Although prognosis is favorable and response to cisplatin-based chemotherapy regimens is good, 10%-20% of patients with thoracic metastases require surgical management following completion of chemotherapy. Pulmonary metastasectomy (PM) has been employed for GCT patients with lung metastases for several decades. Outcomes have been excellent thus far. However, there have been no randomized controlled trials of PM in GCT and, as new surgical techniques are developed, there is variability in management. This article reviews the existing data on current management of pulmonary metastases in GCT, with attention paid to timing of surgery, surgical approaches, and complications.
- Subjects :
- Humans
Lung Neoplasms mortality
Male
Metastasectomy adverse effects
Metastasectomy mortality
Neoplasms, Germ Cell and Embryonal mortality
Postoperative Complications etiology
Risk Factors
Treatment Outcome
Lung Neoplasms secondary
Lung Neoplasms surgery
Metastasectomy methods
Neoplasms, Germ Cell and Embryonal pathology
Neoplasms, Germ Cell and Embryonal surgery
Pneumonectomy adverse effects
Pneumonectomy mortality
Subjects
Details
- Language :
- English
- ISSN :
- 2186-1005
- Volume :
- 25
- Issue :
- 6
- Database :
- MEDLINE
- Journal :
- Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia
- Publication Type :
- Academic Journal
- Accession number :
- 31723083
- Full Text :
- https://doi.org/10.5761/atcs.ra.19-00070